학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 110건 | 목록 1~10
Academic Journal
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Ghobrial IM; Dana-Farber Cancer Institute, Boston, Massachusetts.; Gormley N; Division of Hematology, Food and Drug Administration, Silver Spring, Maryland.; Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.; Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBER-ONC number CB16/12/00233, Salamanca, Spain.; Bergsagel PL; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.; Chesi M; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.; Dhodapkar MV; Winship Cancer Institute of Emory University, Atlanta, Georgia.; Dispenzieri A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.; Fonseca R; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.; Getz G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.; Kristinsson SY; Faculty of Medicine, University of Iceland, Reykjavík, Iceland.; Martinez-Climent JA; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Manier S; Hematology Department, CHU Lille, Lille University, INSERM UMR-S1277, Lille, France.; Marinac CR; Dana-Farber Cancer Institute, Boston, Massachusetts.; Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.; Morgan GJ; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York.; Davies FE; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York.; Nadeem O; Dana-Farber Cancer Institute, Boston, Massachusetts.; Nuvolone M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Paiva B; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; O'Donnell E; Dana-Farber Cancer Institute, Boston, Massachusetts.; Prosper F; Hematology Service and Cell Therapy Unit and Program of Hematology-Oncology CIMA, Clinica Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN) and Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Centro de Investigación Biomedica en Red Cancer (CIBERONC) and RICORS TERAV, Madrid, Spain.; Shah UA; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Sklavenitis-Pistofidis R; Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Sperling AS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Vassiliou GS; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.; Munshi NC; Dana-Farber Cancer Institute, Boston, Massachusetts.; Castle PE; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.; Anderson KC; Dana-Farber Cancer Institute, Boston, Massachusetts.; San Miguel JF; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Academic Journal
Kazandjian D; Sylvester Comprehensive Cancer Center, Miami, FL, United States.; Diamond B; Sylvester Comprehensive Cancer Center, Miami, FL, United States.; Papadimitriou M; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States.; Hill E; National Institutes of Health, United States.; Sklavenitis-Pistofidis R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.; Ziccheddu B; University of Miami Miller School of Medicine, Miami, FL, United States.; Blaney P; NYU Perlmutter Cancer Center, New York, NY, United States.; Chojnacka M; Sylvester Comprehensive Cancer Center, Miami, FL, United States.; Durante M; University of Miami, Miami, FL, United States.; Maclachlan K; Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Young R; National Cancer Institute, Bethesda, MD, United States.; Usmani S; Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Davies F; New York University Langone Medical Center, New York, NY, United States.; Getz G; Broad Institute, Cambridge, MA, United States.; Ghobrial I; Dana-Farber Cancer Institute, Boston, MA, United States.; Korde N; Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Morgan G; New York University Langone Medical Center, New York, NY, United States.; Maura F; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States.; Landgren O; Sylvester Comprehensive Cancer Center, Miami, FL, United States.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Nadeem O; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Aranha MP; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.; Redd R; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Timonian M; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.; Magidson S; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lightbody ED; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.; Alberge JB; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.; Bertamini L; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Dutta AK; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; El-Khoury H; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bustoros M; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology and Medical Oncology, Meyer Cancer Center, New York-Presbyterian Hospital, New York, New York, USA.; Laubach JP; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bianchi G; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; O'Donnell E; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Wu T; Broad Institute, Boston, MA, USA.; Tsuji J; Broad Institute, Boston, MA, USA.; Anderson K; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Getz G; Broad Institute, Boston, MA, USA.; Trippa L; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Richardson PG; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Sklavenitis-Pistofidis R; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.; Ghobrial IM; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Academic Journal
Fléchon L; Canther, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Arib I; Canther, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Dutta AK; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Hasan Bou Issa L; Canther, Lille, France.; Sklavenitis-Pistofidis R; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Tilmont R; CHRU Lille, Lille, France.; Stewart C; Broad Institute, Cambridge, Massachusetts, United States.; Dubois R; CHRU de Lille, Lille, France.; Poulain S; CHRU de Lille, Lille, France.; Copin MC; CHU Angers, ANGERS, France.; Javed S; CH Valenciennes, Valenciennes, France.; Nudel M; CHRU Lille, Lille, France.; Cavalieri D; CHU Lille, Lille, France.; Escure G; CHU Lille, Lille, France.; Gower N; CHU Lille, Lille, France.; Chauvet P; CHU Lille, Lille, France.; Gazeau N; CHU-Lille, Lille, France.; Saade C; CHU Lille, Lille, France.; Thiam MB; CHU Lille, Lille, France.; Ouelkite-Oumouchal A; Canther, Lille, France.; Gaggero S; Canther, Lille, France.; Cailliau É; CHU Lille, Lille, France.; Faiz S; CHRU de Lille, Lille, France.; Carpentier O; CH Roubaix, Roubaix, France.; Duployez N; CHU Lille, Lille, France.; Idziorek TB; Inserm, Lille, France.; Mortier L; Claude Huriez University Hospital, Lille, France.; Figeac M; Lille University, Lille, France.; Preudhomme C; chru of Lille, Lille, France.; Quesnel B; CHU Lille, Lille, France.; Mitra S; UMR 9020-UMR-S 1277-Canther, Institut de Recherche contre le Cancer de Lille, University Lille, CNRS, Inserm, CHU Lille, F-59000 Lille, France, Lille, France.; Morschhauser F; University of Lille, Lille, France.; Getz G; Broad Institute, Mass General Hospital, Cambridge, Massachusetts, United States.; Ghobrial IM; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Manier S; Canther, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Hasan Bou Issa L; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Fléchon L; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Laine W; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Ouelkdite A; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Gaggero S; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Cozzani A; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Tilmont R; Department of Hematology, CHU Lille, 59000 Lille, France.; Chauvet P; Department of Hematology, CHU Lille, 59000 Lille, France.; Gower N; Department of Hematology, CHU Lille, 59000 Lille, France.; Sklavenitis-Pistofidis R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Brinster C; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Thuru X; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Touil Y; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Quesnel B; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Department of Hematology, CHU Lille, 59000 Lille, France.; Mitra S; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Ghobrial IM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Kluza J; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Manier S; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Department of Hematology, CHU Lille, 59000 Lille, France.
Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Sklavenitis-Pistofidis, R.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어